Mawdsley-Brooks & Company Limited is recalling specific batches of Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for injection as a precautionary measure, due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.
Further information, advice and details of the affected batches can be found on the MHRA website.